|
Market Closed -
NYSE
21:00:00 10/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.730 USD | +2.25% |
|
+5.41% | +51.67% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 215M 185M 175M 159M 298M 20.53B 301M 2.08B 800M 10.45B 808M 790M 33.22B | P/E 2026 * |
11.4x | P/E 2027 * | 54.6x |
|---|---|---|---|---|---|
| Enterprise Value | 215M 185M 175M 159M 298M 20.53B 301M 2.08B 800M 10.45B 808M 790M 33.22B | EV / Sales 2026 * |
2.62x | EV / Sales 2027 * | 3.24x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PLX | Delayed | |
CBOE
| PLX | Real-time | |
|
Boerse Muenchen
| PBDA | Real-time | |
|
Tradegate
| PBDA | Real-time | |
|
Börse Stuttgart
| PBDA | Delayed | |
|
Deutsche Boerse AG
| PBDA | Delayed |
Last Transcript : Protalix BioTherapeutics, Inc.
| 1 day | +2.25% | ||
| 1 week | +5.41% | ||
| Current month | +6.23% | ||
| 1 month | +10.98% | ||
| 3 months | +37.88% | ||
| 6 months | -5.21% | ||
| Current year | +51.67% |
| 1 week | 2.6 |  | 2.74 |
| 1 month | 2.17 | | 2.74 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.6 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 29/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 23/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 30/06/2008 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 31/10/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 29/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/09/26 | Free | Chairman | 25,500 | 0.0316% | ||
| 03/09/26 | Free | Chief Executive Officer | 480,000 | 0.5957% | ||
| 03/09/26 | Free | Director | 25,500 | 0.0316% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.25% | +5.41% | +58.72% | +53.37% | 215M | |
| -0.11% | -3.20% | +49.61% | +91.49% | 1,002B | |
| -0.27% | -3.22% | +50.51% | +65.89% | 644B | |
| +1.63% | -2.57% | +21.19% | +71.12% | 443B | |
| -0.63% | -1.06% | +28.11% | +34.59% | 343B | |
| +0.43% | -14.61% | +9.88% | +27.26% | 262B | |
| +0.93% | -1.82% | -1.82% | +8.41% | 245B | |
| -2.25% | -13.63% | +36.61% | +47.43% | 212B | |
| -0.90% | -5.09% | -15.47% | -57.75% | 199B | |
| -0.58% | -3.21% | +25.10% | +90.54% | 181B | |
| Average | +0.05% | -4.19% | +26.24% | +43.23% | 352.99B | |
| Weighted average by Cap. | -0.06% | -4.24% | +31.90% | +57.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 82.16M 70.78M 66.81M 60.81M 114M 7.84B 115M 794M 306M 3.99B 309M 302M 12.69B | 66.48M 57.27M 54.06M 49.21M 91.96M 6.34B 92.9M 643M 247M 3.23B 250M 244M 10.27B |
| Net income | 19.63M 16.91M 15.97M 14.53M 27.16M 1.87B 27.43M 190M 73.04M 953M 73.72M 72.1M 3.03B | 3.79M 3.27M 3.09M 2.81M 5.25M 362M 5.3M 36.69M 14.12M 184M 14.25M 13.93M 586M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | US$2.730 | +2.25% | 782,272 |
| 09/09/26 | US$2.670 | +0.75% | 580,004 |
| 08/09/26 | US$2.650 | -0.75% | 908,363 |
| 04/09/26 | US$2.670 | +1.91% | 863,718 |
| 03/09/26 | US$2.620 | +1.16% | 942,012 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
